Details

Last Funding Type

Seed

Last Funding Money Raised

$10M

Industries

Artificial Intelligence,Cloud Computing,Product Research

Founded date

Jan 1, 2019

Number Of Employee

11 - 50

Operating Status

Active

Galixir is an artificial intelligence technology to promote the research and development of new drugs. Our artificial intelligence drug discovery platform can help drug research and development scientists greatly save time and cost in drug development. At the same time, our platform also provides comprehensive patent protection coverage for the drugs developed. Relying on cutting-edge artificial intelligence technology, Xingyao combines engineering chemistry, computational chemistry, computational biology, and cloud computing technologies to serve the various processes of drug development.